Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (1-10 of 379) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
ABVD or BEACOPP for Advanced Hodgkin LymphomaAndreas Engert
Haematologica|August 2, 2013
CD30-positive malignant lymphomas: time for a change of management?Andreas Engert
Hematological Oncology|June 13, 2019
Treatment of elderly Hodgkin lymphoma patientsAndreas Engert
Lancet (London, England)|March 23, 2015
Hodgkin's lymphoma: who needs consolidation treatment?Andreas Engert
Hematological Oncology|June 11, 2015
XVII. Treatment of advanced-stage Hodgkin lymphomaAndreas Engert
Hemasphere|June 7, 2021
The Fifth Year of <i>HemaSphere</i>Jan Cools, Andreas Engert
Oncotarget|January 26, 2019
Examining rare side effects in pooled trial data: symptomatic osteonecrosis in Hodgkin lymphomaSven Borchmann, Andreas Engert
Acta Haematologica|December 15, 2010
Meta-analyses of early-stage hodgkin lymphomaChristine Herbst, Andreas Engert
Hematology. American Society of Hematology. Education Program|January 18, 2011
The past: what we have learned in the last decadePeter Borchmann, Andreas Engert
Seminars in Hematology|August 7, 2016
Treatment of early-stage Hodgkin lymphomaAndreas Engert, John Raemaekers
Pageof 38

Showing results (1-10 of 379) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
ABVD or BEACOPP for Advanced Hodgkin LymphomaAndreas Engert
Haematologica|August 2, 2013
CD30-positive malignant lymphomas: time for a change of management?Andreas Engert
Hematological Oncology|June 13, 2019
Treatment of elderly Hodgkin lymphoma patientsAndreas Engert
Lancet (London, England)|March 23, 2015
Hodgkin's lymphoma: who needs consolidation treatment?Andreas Engert
Hematological Oncology|June 11, 2015
XVII. Treatment of advanced-stage Hodgkin lymphomaAndreas Engert
Hemasphere|June 7, 2021
The Fifth Year of <i>HemaSphere</i>Jan Cools, Andreas Engert
Oncotarget|January 26, 2019
Examining rare side effects in pooled trial data: symptomatic osteonecrosis in Hodgkin lymphomaSven Borchmann, Andreas Engert
Acta Haematologica|December 15, 2010
Meta-analyses of early-stage hodgkin lymphomaChristine Herbst, Andreas Engert
Hematology. American Society of Hematology. Education Program|January 18, 2011
The past: what we have learned in the last decadePeter Borchmann, Andreas Engert
Seminars in Hematology|August 7, 2016
Treatment of early-stage Hodgkin lymphomaAndreas Engert, John Raemaekers
Pageof 38